- Home
- AUTL vs VREX Comparison
AUTL vs VREX Comparison
Compare AUTL & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- VREX
- Stock Information
- Founded
- AUTL 2014
- VREX 2016
- Country
- AUTL United Kingdom
- VREX United States
- Employees
- AUTL N/A
- VREX N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- VREX Industrial Machinery/Components
- Sector
- AUTL Health Care
- VREX Technology
- Exchange
- AUTL Nasdaq
- VREX Nasdaq
- Market Cap
- AUTL 625.4M
- VREX 483.7M
- IPO Year
- AUTL 2018
- VREX N/A
- Fundamental
- Price
- AUTL $1.27
- VREX $11.60
- Analyst Decision
- AUTL Strong Buy
- VREX Strong Buy
- Analyst Count
- AUTL 5
- VREX 2
- Target Price
- AUTL $9.12
- VREX $19.50
- AVG Volume (30 Days)
- AUTL 4.4M
- VREX 336.5K
- Earning Date
- AUTL 11-11-2025
- VREX 08-07-2025
- Dividend Yield
- AUTL N/A
- VREX N/A
- EPS Growth
- AUTL N/A
- VREX N/A
- EPS
- AUTL N/A
- VREX N/A
- Revenue
- AUTL $29,934,000.00
- VREX $821,400,000.00
- Revenue This Year
- AUTL $641.63
- VREX $5.01
- Revenue Next Year
- AUTL $109.21
- VREX $2.97
- P/E Ratio
- AUTL N/A
- VREX N/A
- Revenue Growth
- AUTL 185.17
- VREX N/A
- 52 Week Low
- AUTL $1.11
- VREX $6.76
- 52 Week High
- AUTL $5.00
- VREX $16.93
- Technical
- Relative Strength Index (RSI)
- AUTL 24.20
- VREX 61.49
- Support Level
- AUTL $1.30
- VREX $10.85
- Resistance Level
- AUTL $1.46
- VREX $11.74
- Average True Range (ATR)
- AUTL 0.09
- VREX 0.48
- MACD
- AUTL 0.01
- VREX -0.11
- Stochastic Oscillator
- AUTL 2.63
- VREX 69.83
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.